SSTC3
Modify Date: 2024-01-20 18:29:49
SSTC3 structure
|
Common Name | SSTC3 | ||
|---|---|---|---|---|
| CAS Number | 1242422-09-8 | Molecular Weight | 518.529 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H17F3N4O3S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SSTC3SSTC3 is a novel small-molecule CK1α activator with EC50 of 30 nM (WNT-driven reporter gene assay), Kd of 32 nM; has better pharmacokinetic properties than pyrvinium, attenuates the growth of such Apc mutant organoids with EC50 of 2.9 uM; decreases the viability of the WNT-dependent cell lines (EC50 = 132, 63, and 123 nM for HT29, SW403, and HCT116 cells, respectively), inhibits the growth of CRC xenografts in mice; also attenuates the growth of patient-derived metastatic CRC xenograft, with minimal gastrointestinal toxicity compared to other classes of WNT inhibitors. |
| Name | SSTC3 |
|---|
| Description | SSTC3 is a novel small-molecule CK1α activator with EC50 of 30 nM (WNT-driven reporter gene assay), Kd of 32 nM; has better pharmacokinetic properties than pyrvinium, attenuates the growth of such Apc mutant organoids with EC50 of 2.9 uM; decreases the viability of the WNT-dependent cell lines (EC50 = 132, 63, and 123 nM for HT29, SW403, and HCT116 cells, respectively), inhibits the growth of CRC xenografts in mice; also attenuates the growth of patient-derived metastatic CRC xenograft, with minimal gastrointestinal toxicity compared to other classes of WNT inhibitors. |
|---|---|
| References | References 1. Li B, et al. Sci Signal. 2017 Jun 27;10(485). pii: eaak9916. View Related Products by Target Casein Kinase |
| Molecular Formula | C23H17F3N4O3S2 |
|---|---|
| Molecular Weight | 518.529 |